This review provides an overview of the distinctive structural characteristics of KIR2DL4, followed by an examination of its expression within the immune microenvironment of tumor and the potential utility of targeting KIR2DL4 in cancer immunotherapy. This evidence concerns the gene KIR2DL4 and neoplasm.